Answer
Oxlumo (lumasiran sodium) may be considered during pregnancy after weighing the expected health benefit for the woman against potential risks to the foetus; there are no data in pregnant women, although animal studies indicate no direct or indirect reproductive harm.
Sources for this answer
- Oxlumo 94.5 mg/0.5 mL solution for injectionAlnylam UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 8Document updated
Sources checked